NEULANDLABPharmaceuticals
Neuland Laboratories Ltd — Balance Sheet
₹12027.00
-1.94%
Neuland Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible Book Value | 1.24K Cr | 1.00K Cr | 713.33 Cr | 558.92 Cr | — |
| Working Capital | 673.81 Cr | 493.40 Cr | 321.94 Cr | 217.64 Cr | — |
| Net Tangible Assets | 1.24K Cr | 1.00K Cr | 713.33 Cr | 558.92 Cr | — |
| Capital Lease Obligations | 21.13 Cr | 12.88 Cr | 6.94 Cr | 9.59 Cr | — |
| Common Stock Equity | 1.52K Cr | 1.28K Cr | 994.10 Cr | 840.50 Cr | — |
| Total Capitalization | 1.62K Cr | 1.33K Cr | 1.07K Cr | 944.75 Cr | — |
| Total Equity Gross Minority Interest | 1.52K Cr | 1.28K Cr | 994.10 Cr | 840.50 Cr | — |
| Stockholders Equity | 1.52K Cr | 1.28K Cr | 994.10 Cr | 840.50 Cr | — |
| Other Equity Interest | 1.51K Cr | 1.27K Cr | 981.20 Cr | 827.60 Cr | — |
| Fixed Assets Revaluation Reserve | 0.84 Cr | 0.84 Cr | 0.84 Cr | 0.84 Cr | — |
| Retained Earnings | 994.63 Cr | 752.48 Cr | 465.23 Cr | 308.13 Cr | — |
| Additional Paid In Capital | 497.77 Cr | 497.77 Cr | 497.77 Cr | 497.77 Cr | — |
| Capital Stock | 12.90 Cr | 12.90 Cr | 12.90 Cr | 12.90 Cr | — |
| Common Stock | 12.90 Cr | 12.90 Cr | 12.90 Cr | 12.90 Cr | — |
| Total Liabilities Net Minority Interest | 655.08 Cr | 549.86 Cr | 585.67 Cr | 542.99 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 189.39 Cr | 122.17 Cr | 146.71 Cr | 179.83 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 7.22 Cr | 7.61 Cr | 10.29 Cr | 11.91 Cr | — |
| Non Current Deferred Taxes Liabilities | 72.82 Cr | 60.44 Cr | 58.30 Cr | 56.70 Cr | — |
| Long Term Debt And Capital Lease Obligation | 109.34 Cr | 54.12 Cr | 78.09 Cr | 111.19 Cr | — |
| Long Term Capital Lease Obligation | 18.62 Cr | 9.20 Cr | 3.85 Cr | 6.94 Cr | — |
| Long Term Debt | 90.73 Cr | 44.92 Cr | 74.25 Cr | 104.25 Cr | — |
| Long Term Provisions | 7.22 Cr | 7.61 Cr | 10.29 Cr | 11.91 Cr | — |
| Current Liabilities | 465.69 Cr | 427.68 Cr | 438.96 Cr | 363.16 Cr | — |
| Other Current Liabilities | 6.31 Cr | 4.96 Cr | 3.56 Cr | 3.62 Cr | — |
| Current Debt And Capital Lease Obligation | 47.79 Cr | 41.27 Cr | 50.36 Cr | 129.34 Cr | — |
| Current Capital Lease Obligation | 2.51 Cr | 3.68 Cr | 3.09 Cr | 2.65 Cr | — |
| Current Debt | 45.28 Cr | 37.59 Cr | 47.26 Cr | 126.70 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 29.58 Cr | 46.62 Cr | 17.54 Cr | 9.56 Cr | — |
| Current Provisions | 2.10 Cr | 1.64 Cr | 1.53 Cr | 66.84 Cr | — |
| Payables | 260.65 Cr | 199.86 Cr | 189.64 Cr | 125.80 Cr | — |
| Other Payable | 8.16 Cr | 7.68 Cr | 8.12 Cr | 8.30 Cr | — |
| Dividends Payable | 0.20 Cr | 0.14 Cr | 0.12 Cr | 0.12 Cr | — |
| Total Tax Payable | 0.09 Cr | 0.08 Cr | 10.40 Cr | 0.00 | — |
| Accounts Payable | 252.20 Cr | 191.96 Cr | 171.01 Cr | 117.38 Cr | — |
| Total Assets | 2.18K Cr | 1.83K Cr | 1.58K Cr | 1.38K Cr | — |
| Total Non Current Assets | 1.04K Cr | 911.48 Cr | 818.87 Cr | 802.70 Cr | — |
| Other Non Current Assets | 15.60 Cr | 21.82 Cr | 3.97 Cr | 1.39 Cr | — |
| Non Current Prepaid Assets | 9.82 Cr | 9.10 Cr | 9.86 Cr | 9.23 Cr | — |
| Investmentin Financial Assets | 1.53 Cr | 1.28 Cr | 0.52 Cr | 0.50 Cr | — |
| Available For Sale Securities | 1.53 Cr | 1.28 Cr | 0.52 Cr | 0.48 Cr | — |
| Investment Properties | 0.00 | 19.03 Cr | 19.34 Cr | 19.66 Cr | — |
| Goodwill And Other Intangible Assets | 284.31 Cr | 281.92 Cr | 280.76 Cr | 281.58 Cr | — |
| Other Intangible Assets | 4.85 Cr | 2.46 Cr | 1.30 Cr | 2.12 Cr | — |
| Goodwill | 279.46 Cr | 279.46 Cr | 279.46 Cr | 279.46 Cr | — |
| Net PPE | 733.40 Cr | 589.79 Cr | 499.83 Cr | 486.58 Cr | — |
| Accumulated Depreciation | -268.90 Cr | -256.77 Cr | -204.87 Cr | -159.52 Cr | — |
| Gross PPE | 1.00K Cr | 846.56 Cr | 704.69 Cr | 646.10 Cr | — |
| Construction In Progress | 59.68 Cr | 67.07 Cr | 42.39 Cr | 20.46 Cr | — |
| Other Properties | 673.71 Cr | 522.72 Cr | 457.43 Cr | 9.00 Cr | — |
| Machinery Furniture Equipment | 655.35 Cr | 533.64 Cr | 463.48 Cr | 433.73 Cr | — |
| Buildings And Improvements | 254.17 Cr | 217.10 Cr | 188.07 Cr | 181.17 Cr | — |
| Land And Improvements | 33.09 Cr | 28.75 Cr | 10.74 Cr | 10.74 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 1.14K Cr | 921.08 Cr | 760.89 Cr | 580.79 Cr | — |
| Other Current Assets | 69.30 Cr | 0.12 Cr | 53.76 Cr | 55.21 Cr | — |
| Restricted Cash | 14.32 Cr | 14.21 Cr | 13.69 Cr | 15.27 Cr | — |
| Prepaid Assets | 63.04 Cr | 70.71 Cr | 50.69 Cr | 49.78 Cr | — |
| Inventory | 385.76 Cr | 350.42 Cr | 279.23 Cr | 265.21 Cr | — |
| Finished Goods | 68.59 Cr | 89.03 Cr | 63.70 Cr | 52.67 Cr | — |
| Work In Process | 155.30 Cr | 147.70 Cr | 117.89 Cr | 119.41 Cr | — |
| Raw Materials | 161.86 Cr | 113.69 Cr | 97.65 Cr | 93.13 Cr | — |
| Other Receivables | 8.48 Cr | 9.51 Cr | 10.10 Cr | 7.15 Cr | — |
| Accounts Receivable | 315.72 Cr | 373.53 Cr | 361.77 Cr | 234.33 Cr | — |
| Allowance For Doubtful Accounts Receivable | -2.38 Cr | -0.63 Cr | -3.53 Cr | -4.21 Cr | — |
| Gross Accounts Receivable | 318.10 Cr | 374.16 Cr | 365.29 Cr | 238.53 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 352.18 Cr | 102.59 Cr | 45.42 Cr | 8.47 Cr | — |
| Other Short Term Investments | 220.25 Cr | 15.01 Cr | 20.72 Cr | 3.38 Cr | — |
| Cash And Cash Equivalents | 131.93 Cr | 87.58 Cr | 45.42 Cr | 5.09 Cr | — |
| Cash Equivalents | 63.05 Cr | 77.06 Cr | 25.01 Cr | — | — |
| Cash Financial | 68.88 Cr | 10.52 Cr | 20.41 Cr | 5.09 Cr | — |
| Ordinary Shares Number | 1.28 Cr | 1.28 Cr | 1.28 Cr | 1.28 Cr | — |
| Share Issued | 1.28 Cr | 1.28 Cr | 1.28 Cr | 1.28 Cr | — |
| Net Debt | 4.08 Cr | — | 76.09 Cr | 225.85 Cr | 167.74 Cr |
| Total Debt | 157.14 Cr | 95.39 Cr | 128.45 Cr | 240.53 Cr | — |
| Invested Capital | 1.66K Cr | 1.37K Cr | 1.12K Cr | 1.07K Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Other Non Current Liabilities | — | — | 0.03 Cr | 0.03 Cr | 2.87 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | — | 0.02 Cr | 0.02 Cr | 0.02 Cr |
| Hedging Assets Current | — | — | 0.00 | 0.59 Cr | 0.00 |
| Non Current Deferred Revenue | — | — | — | 0.00 | 0.03 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Neuland Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.